NMTC — NEUROONE MEDICAL TECHNOLOGIES Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1500198 ·
Last close
$0.71
Market Cap
$6.43M
52W High
$6.12
52W Low
$0.71
ADV30
78,287
Next earnings
2026-12-15
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,973,105 | 1,182,609 | -2,424,312 | -2,006,331 | 6,186,095 | 2,047,596 | 2,418,552 |
| Mar 2026 | 1,862,050 | 990,264 | -2,397,197 | -2,382,022 | 7,864,958 | 2,804,011 | 2,491,322 |
| Dec 2025 | 2,892,635 | 1,567,828 | -1,707,307 | -1,437,890 | 8,577,602 | 3,561,616 | 2,175,677 |
| Sep 2025 | 2,740,925 | 1,528,621 | -1,371,064 | -1,619,221 | 10,785,647 | 6,570,382 | 3,713,125 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,052,007
Investing CF
$-109,536
Financing CF
$1,169,456
CapEx
$-109,536
Dividends Paid
—
Buybacks
$-70,356
EPS Diluted TTM
$-0.88
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-84,436,030
Inventory
$2,290,254
Receivables
$1,098,965
ST Investments
—
EBIT TTM
$-7,445,464
Pretax Income TTM
$-7,445,464
Interest Exp TTM
$0
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$12,468,715
EBITDA
$-7,663,002
Free Cash Flow
$-4,566,159
Enterprise Value
$12,332,739
Total Cash
$2,047,596
Total Debt
$175,345
Shares Out
9,105,763
Trailing EPS
$-0.97
Book Value
$0.43
ROE
-124.7%
ROA
-58.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 9,097,692 | -4,226,473 | -3,605,374 | 10,785,647 | 3,713,125 | 7,072,522 | -2,837,272 |
| Sep 2024 | 3,453,003 | -11,887,209 | -12,318,110 | 5,369,940 | 4,547,927 | 822,013 | -11,011,840 |
| Sep 2023 | 1,952,441 | -11,955,250 | -11,859,491 | 8,097,314 | 1,847,910 | 6,249,404 | -12,886,874 |
| Sep 2022 | 171,169 | -10,030,765 | -9,999,613 | 12,822,609 | 3,218,245 | 9,604,364 | -7,519,534 |
TTM Snapshot
Revenues TTM
$9,997,850
NetIncome TTM
$-7,149,111
OpCashFlow TTM
—
Assets (Latest)
$6,186,095
Forward EPS
$-0.28
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| STME | Stimcell Energetics Inc. | $6.34M | $0.30 | — |
| CLGN | CollPlant Biotechnologies Ltd | $6.30M | $3.33 | — |
| NDRA | ENDRA Life Sciences Inc. | $5.88M | $3.92 | — |
| ARAY | ACCURAY INC | $7.33M | $2.44 | — |
| USAQ | QHSLab, Inc. | $5.52M | $0.37 | — |
News headlines (Yahoo Finance, 1h cache)
INEO Appoints David Wambeke to Board of Directors
2026-11-03 12:00 · Yahoo
NeuroOne® Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation System
2026-10-29 12:00 · Yahoo
NeuroOne Featured in New York Post on OneRF® Patient’s Remarkable Journey to Overcome Debilitating Facial Pain
2026-10-27 12:00 · Yahoo
NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program
2026-10-22 12:31 · Yahoo
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
2026-10-08 20:01 · Yahoo
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
2026-10-05 13:17 · Yahoo
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform
2026-08-27 13:05 · Yahoo
NeuroOne (NMTC) Q3 2026 Earnings Call Transcript
2026-08-20 15:13 · Yahoo
NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Call Highlights: Revenue Grows 16% ...
2026-08-17 19:03 · Yahoo
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time
2026-08-03 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.